Piper Sandler & Co’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-98
Closed -$7K 29
2021
Q3
$7K Buy
+98
New +$7K 0.01% 19